Syncom Formulations (India) Ltd. benchmarking: Performance to industry peers

Financial

	Syncom Formulations	Sakar Healthcare	Fredun Pharma
Operational Metrics
Financials
5 yr Average ROE	9.79 %	8.14 %	11.84 %
5yr average Equity Multiplier	1.41	1.76	2.85
5yr Average Asset Turnover Ratio	0.81	0.45	1.08
5yr Avg Net Profit Margin	8.78 %	10.03 %	3.9 %
Price to Book	3.38	3.91	8.28
P/E	18.54	41.58	39.83
5yr Avg Cash Conversion Cycle	61.57 Days	18.72 Days	175.29 Days
Inventory Days	27.32 Days	51.79 Days	146.68 Days
Days Receivable	82.75 Days	53.06 Days	142.46 Days
Days Payable	79.41 Days	115.64 Days	112.95 Days
5yr Average Interest Coverage Ratio	31.44	4.85	2.62
5yr Avg ROCE	13.63 %	8.92 %	22.71 %
5yr Avg Operating Profit Margin	9.97 %	24.94 %	9.7 %
5 yr average Debt to Equity	0.19	0.49	0.93
5yr CAGR Net Profit	36.24 %	10.38 %	25.5 %
5yr Average Return on Assets	7.11 %	4.54 %	4.18 %
Shareholdings
Promoter Holding	50.57 %	52.86 %	44.17 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-7.86 %	-5.98 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Syncom Formulations	Sakar Healthcare	Fredun Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 99.26 Rental Income 0.73 Commodity 0.01 Loan Licensing 0 Export 0 CDMO 0 Pharmaceuticals 0 0	Product Wise Break-Up Export 73.0 Pharmaceutical 0 Rental Income 0 CDMO 22.0 Pharmaceuticals 0 0 Commodity 0 Loan Licensing 5.0	Product Wise Break-Up Export 0 Pharmaceutical 0 Rental Income 0 CDMO 0 Pharmaceuticals 0 Pharmaceutical 100.0 Commodity 0 Loan Licensing 0
Location Wise Break-Up	Location Wise Break-Up International 84.5 Domestic 15.5 Rest of the World 0 India 0	Location Wise Break-Up International 55.48 India 0 Rest of the World 0 Domestic 44.52	Location Wise Break-Up International 0 India 83.13 Rest of the World 16.86 Domestic 0 Others 0.01
Drug Delivery Break-Up	Drug Delivery Break-Up Tablets 79.76 Injectables 6.08 Capsules 2.14 Liquids 1.82 Ointment 1.0 Dry Powder 0.49 Others 8.71	-	-
Capex	Capex Formulations 100.0 Trading of Commodities 0 Renting of Property 0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical Drugs & Formulations 96.65 Renting of Property 2.99 Trading of Commodities 0.01 Others 0.35	-	-
Raw Material Break-Up	Raw Material Break-Up Tapentadol Hydrochloride 53.16 Packing Material 14.34 Paracetamol 3.0 CEFTRIAXONE SODIUM 0.78 Ibuprofen 0.74 Others 27.98	-	-
Asset Break-Up	Asset Break-Up Formulations 91.86 Renting of Property 7.78 Trading of Commodities 0.36	-	-